Nutrient-based therapies for bipolar disorder: a systematic review (Q38059360)

28 August 2017

Nutrient-based therapies for bipolar disorder: a systematic review (English)

1 reference

28 August 2017

1 reference

Louisa G Sylvia

1

1 reference

28 August 2017

Amy T Peters

series ordinal

2

1 reference

28 August 2017

Thilo Deckersbach

series ordinal

3

1 reference

28 August 2017

Andrew A Nierenberg

series ordinal

4

1 reference

28 August 2017

6 November 2012

1 reference

Psychotherapy and Psychosomatics

28 August 2017

1 reference

28 August 2017

82

1 reference

28 August 2017

1

1 reference

28 August 2017

10-19

1 reference

Prodromal and residual symptoms in bipolar I disorder.

28 August 2017

1 reference

Treatment non-adherence in affective disorders.

21 January 2018

1 reference

Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials

21 January 2018

1 reference

Bipolar disorder: improving diagnosis and optimizing integrated care

21 January 2018

1 reference

Optimal diets for prevention of coronary heart disease

21 January 2018

1 reference

The role of fish oils in the treatment of rheumatoid arthritis

21 January 2018

1 reference

Role of essential fatty acids in the function of the developing nervous system

21 January 2018

1 reference

Mechanisms of action of docosahexaenoic acid in the nervous system

21 January 2018

1 reference

Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes

21 January 2018

1 reference

A pilot open case series of ethyl-EPA supplementation in the treatment of anorexia nervosa

21 January 2018

1 reference

Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers

21 January 2018

1 reference

Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients

21 January 2018

1 reference

Essential fatty acids, prostaglandins, and alcoholism: an overview

21 January 2018

1 reference

Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder

21 January 2018

1 reference

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms

21 January 2018

1 reference

Nutrition and exercise behavior among patients with bipolar disorder.

21 January 2018

1 reference

Nutritional therapies for mental disorders

21 January 2018

1 reference

Vitamin and mineral intakes in adults with mood disorders: comparisons to nutrition standards and associations with sociodemographic and clinical variables

21 January 2018

1 reference

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

21 January 2018

1 reference

Unmasking special interest groups: the key to addressing conflicts of interest in medicine.

21 January 2018

1 reference

Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils

21 January 2018

1 reference

Therapeutic use of omega-3 fatty acids in bipolar disorder.

21 January 2018

1 reference

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

21 January 2018

1 reference

Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study

21 January 2018

1 reference

Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.

21 January 2018

1 reference

Omega-3 Eicosapentaenoic Acid in Bipolar Depression

21 January 2018

1 reference

Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study

21 January 2018

1 reference

Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation.

21 January 2018

1 reference

Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial.

21 January 2018

1 reference

Omega-3 fatty acids in bipolar disorder: clinical and research considerations

21 January 2018

1 reference

Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder

21 January 2018

1 reference

Double-blind, controlled trial of inositol treatment of depression

21 January 2018

1 reference

Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone

21 January 2018

1 reference

Inositol as an add-on treatment for bipolar depression.

21 January 2018

1 reference

Inositol augmentation of lithium or valproate for bipolar depression.

21 January 2018

1 reference

Oral choline decreases brain purine levels in lithium-treated subjects with rapid-cycling bipolar disorder: a double-blind trial using proton and lithium magnetic resonance spectroscopy

21 January 2018

1 reference

Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia

21 January 2018

1 reference

Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder

21 January 2018

1 reference

Translational research in bipolar disorder: emerging insights from genetically based models

21 January 2018

1 reference

Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders

21 January 2018

1 reference

Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research

21 January 2018

1 reference

Magnetic resonance imaging studies in early-onset bipolar disorder: a critical review

21 January 2018

1 reference

Neurochemical alterations in adolescent bipolar depression: a proton magnetic resonance spectroscopy pilot study of the prefrontal cortex

21 January 2018

1 reference

A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence.

21 January 2018

1 reference

Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients.

21 January 2018

1 reference

Anticonvulsants in bipolar disorders: current research and practice and future directions

21 January 2018

1 reference

Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen

21 January 2018

1 reference

Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder

21 January 2018

1 reference

Magnesium and affective disorders

21 January 2018

1 reference

Antimanic effects of verapamil

21 January 2018

1 reference

Magnesium oxide augmentation of verapamil maintenance therapy in mania

21 January 2018

1 reference

Treatment of severe mania with intravenous magnesium sulphate as a supplementary therapy.

21 January 2018

1 reference

A pilot study of magnesium aspartate hydrochloride (Magnesiocard) as a mood stabilizer for rapid cycling bipolar affective disorder patients

21 January 2018

1 reference

Longevity effect of chromium picolinate--'rejuvenation' of hypothalamic function?

21 January 2018

1 reference

Effectiveness of chromium in atypical depression: a placebo-controlled trial

21 January 2018

1 reference

The Effect of Stimulant Treatment for ADHD on Later Substance Abuse and the Potential for Medication Misuse, Abuse, and Diversion

21 January 2018

1 reference

B vitamins, cognition, and aging: a review

21 January 2018

1 reference

Enhancement of recovery from psychiatric illness by methylfolate.

21 January 2018

1 reference

Serum and red cell folate and affective morbidity in lithium prophylaxis

21 January 2018

1 reference

Comparison of cognitive functions between first- and multi-episode bipolar affective disorders

21 January 2018

1 reference

Folic acid, ageing, depression, and dementia

21 January 2018

1 reference

Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial.

21 January 2018

1 reference

Red cell folate concentrations in psychiatric patients

21 January 2018

1 reference

The role of folic acid in prevention and treatment of depression: an overview of existing evidence and implications for practice

21 January 2018

1 reference

Tryptophan depletion and its implications for psychiatry

21 January 2018

1 reference

Relapse of depression after rapid depletion of tryptophan.

21 January 2018

1 reference

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

21 January 2018

1 reference

Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse.

21 January 2018

1 reference

Serotonergic 'vulnerability' in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram-responders.

21 January 2018

1 reference

Effects on mood of acute phenylalanine/tyrosine depletion in healthy women

21 January 2018

1 reference

Rapid tryptophan depletion as a treatment for acute mania: a double-blind, pilot-controlled study

21 January 2018

1 reference

A controlled clinical trial of L-tryptophan in acute mania

21 January 2018

1 reference

Diet quality in bipolar disorder in a population-based sample of women.

21 January 2018

1 reference

A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning

21 January 2018

1 reference

Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder

21 January 2018

1 reference

Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort.

21 January 2018

1 reference

Association of Western and traditional diets with depression and anxiety in women

21 January 2018

1 reference

Dietary pattern and depressive symptoms in middle age.

21 January 2018

1 reference

Red meat consumption and mood and anxiety disorders.

21 January 2018

1 reference

Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial

21 January 2018

1 reference

Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors

21 January 2018

1 reference

Exercise treatment for bipolar disorder: potential mechanisms of action mediated through increased neurogenesis and decreased allostatic load

21 January 2018

1 reference

A randomized controlled trial of cognitive behavioral group therapy for bipolar disorder.

21 January 2018

1 reference

Development of an integrated psychosocial treatment to address the medical burden associated with bipolar disorder

21 January 2018

1 reference

Treatment of cyclothymic disorder: commentary.

21 January 2018

1 reference

The sequential combination of cognitive behavioral treatment and well-being therapy in cyclothymic disorder.

21 January 2018

1 reference

A 2-Year, Open-Label Pilot Study of Adjunctive Chromium in Patients With Treatment-Resistant Rapid-Cycling Bipolar Disorder

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000341309

1 reference

28 August 2017

1 reference